All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

clebopride 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
sulpiride derivatives and analogues	670	55905-53-8

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: clebopride clebopride maleate	antidopaminergic; RN given refers to parent cpd; structure Molecular weight: 373.88 Formula: C20H24ClN3O2 CLOGP: 2.72 LIPINSKI: 0 HAC: 5 HDO: 2 TPSA: 67.59 ALOGS: -4.28 ROTB: 5

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Property	Description	Value	Unit	Confidence	Similarity
azlogd74	LogD at pH 7.4	2.625		Moderate	0.74
caco2-efflux	Caco-2 efflux ratio (BA/AB)	0.641		Moderate	0.74
caco2-intrinsic-papp	Caco-2 intrinsic apparent permeability	24.831	10^-6 cm/s	Moderate	0.74
dh-clint	Dog hepatocyte intrinsic clearance	12.078	uL/min/10^6 cells	Moderate	0.74
dppb	Dog plasma protein binding (% unbound)	16.860	%	Moderate	0.74
fcs-ppb	Fetal calf serum protein binding (% unbound)	49.830	%	Moderate	0.74
herg	hERG pIC50	5.920	pIC50	Moderate	0.74
hh-clint	Human hepatocyte intrinsic clearance	8.531	uL/min/10^6 cells	Moderate	0.74
hlm-clint	Human liver microsomal intrinsic clearance	34.834	uL/min/mg protein	Moderate	0.74
hppb	Human plasma protein binding (% unbound)	13.070	%	Moderate	0.74
kinase-safety-class	ACVR2B,AKT2,AKT3,ALK,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK1,JAK2,MAP3K21,MAP3K7,MAPK10,MAPK12,MAPK7,MAPK9,MAPKAPK2,MARK4,MET,MTOR,NTRK2,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,TEK,TTK	45
kinase-selectivity-class	AXL,BRAF,CAMK2D,CDK9,EIF2AK3,EPHB4,GRK2,MAPK7,PRKCD,SIK2,SIK3,STK33,TEK	13
mdck-mdr1-efflux	MDCK-MDR1 efflux ratio	1.084		Moderate	0.74
mh-clint	Mouse hepatocyte intrinsic clearance	76.208		Moderate	0.74
mppb	Mouse plasma protein binding (% unbound)	22.420		Moderate	0.74
nih-mdck-mdr1-efflux	NIH MDCK-MDR1 efflux ratio	4.055		Moderate	0.74
pfas-class	PFAS structural alert (1 = True, 0 = False)	0
pppb	Pig plasma protein binding (% unbound)	29.660	%	Moderate	0.74
rh-clint	Rat hepatocyte intrinsic clearance	59.156	uL/min/10^6 cells	Moderate	0.74
rh-fuinc	Rat hepatocyte fraction unbound in incubation	75.040	%	Moderate	0.74
rppb	Rat plasma protein binding (% unbound)	19.420	%	Moderate	0.74
solubility-dd	Solubility at pH 7.4 in DMSO	519.996	uM	Moderate	0.74

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Mixed liver injury	66.83	43.38	10	39	4464	42616822

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Mixed liver injury	60.44	44.55	10	75	12069	110577145

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A03FA06	ALIMENTARY TRACT AND METABOLISM DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS PROPULSIVES Propulsives
MeSH PA	D000932	Antiemetics
MeSH PA	D002491	Central Nervous System Agents
MeSH PA	D005765	Gastrointestinal Agents
MeSH PA	D018373	Peripheral Nervous System Agents

Related Drugs by ATC class:

A03FA Propulsives 9 drugs

acotiamidealizapridebromopridecinitapridecisapridedomperidoneitopridemetoclopramidemosapride

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	10.44	acidic
pKa2	7.98	Basic
pKa3	1.0	Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
D(2) dopamine receptor	GPCR	P14416	DRD2_HUMAN		Ki	7.92		CHEMBL
Potassium voltage-gated channel subfamily H member 2	Ion channel	Q12809	KCNH2_HUMAN		IC50	6.22		CHEMBL
D(3) dopamine receptor	GPCR	P35462	DRD3_HUMAN		Ki	7.98		CHEMBL
D(4) dopamine receptor	GPCR	P21917	DRD4_HUMAN		Ki	8.49		CHEMBL
Acetylcholinesterase	Enzyme	P22303	ACES_HUMAN		IC50	6.05		CHEMBL
5-hydroxytryptamine receptor 4	GPCR		5HT4R_CAVPO		Ki	6.98		CHEMBL
D(2) dopamine receptor	GPCR		DRD2_RAT		Ki	8.95		CHEMBL
D(1A) dopamine receptor	GPCR		DRD1_BOVIN		Ki	5.22		CHEMBL
5-hydroxytryptamine receptor 4	GPCR		5HT4R_RAT		Ki	6.98		CHEMBL
Adrenergic receptor alpha-2	GPCR		ADA2B_RAT ADA2C_RAT ADA2A_RAT		Ki	6.22		CHEMBL
Serotonin 2 (5-HT2) receptor	GPCR		5HT2C_RAT 5HT2A_RAT 5HT2B_RAT		Ki	7.05		CHEMBL

External reference:

ID	Source
D03534	KEGG_DRUG
21224	RXNORM
C0055869	UMLSCUI
CHEBI:92309	CHEBI
CHEMBL325109	ChEMBL_ID
DB13511	DRUGBANK_ID
C014417	MESH_SUPPLEMENTAL_RECORD_UI
2780	PUBCHEM_CID
3699	INN_ID
84370-95-6	SECONDARY_CAS_RN
I0A84520Y9	UNII
006633	NDDF
006634	NDDF
CHEMBL1599248	ChEMBL_ID
I0A84520Y9	INXIGHT DRUGS

Pharmaceutical products:

None